Inactive Instrument

Nexstim Oyj Stock Nasdaq Helsinki

Equities

NXTMH

FI4000102678

Advanced Medical Equipment & Technology

Sales 2024 * 8.6M 9.16M Sales 2025 * 11.2M 11.93M Capitalization 15.7M 16.72M
Net income 2024 * - 0 Net income 2025 * - 0 EV / Sales 2024 * 2.01 x
Net Debt 2024 * 1.6M 1.7M Net Debt 2025 * 900K 959K EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
-29 x
P/E ratio 2025 *
23.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 51.18%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 47 14-08-17
Director of Finance/CFO 38 14-04-30
Chief Tech/Sci/R&D Officer 63 07-12-31
Members of the board TitleAgeSince
Director/Board Member 62 19-11-10
Director/Board Member 53 21-04-30
Director/Board Member 65 21-04-30
More insiders
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
More about the company